Sat Jan 10 05:54:03 UTC 2026: ### Headline: Tainted Syrup Alert Issued in Telangana: Almont Kid Syrup Recalled Due to Ethylene Glycol Contamination

The Story: The Telangana Drugs Control Administration (DCA) issued a public alert on January 10, 2026, regarding a specific batch of ‘Almont Kid Syrup’ contaminated with toxic Ethylene Glycol (EG). This alert follows testing conducted by the Central Drugs Standard Control Organization (CDSCO) in Kolkata, which confirmed the presence of the harmful substance. The implicated batch, AL-24002, manufactured in January 2025 by Tridus Remedies in Vaishali, Bihar, is prescribed for treating allergy symptoms in children.

Key Points:

  • The Telangana DCA issued an alert regarding ‘Almont Kid Syrup’ batch AL-24002.
  • The syrup is contaminated with Ethylene Glycol (EG).
  • The batch was manufactured by Tridus Remedies in Vaishali, Bihar, in January 2025.
  • The drug is intended for children to treat allergy symptoms.
  • Retailers, wholesalers, distributors, and hospitals have been directed to freeze stocks of the implicated batch.
  • The public is advised to immediately stop using the syrup and report it to the DCA.
  • A DCA toll-free number, 1800-599-6969, is available during working hours (10:30 a.m. to 5:00 p.m.) on working days.

Key Takeaways:

  • The contamination of children’s medication with a toxic substance poses a significant public health risk.
  • The prompt action by the Telangana DCA and CDSCO in identifying and issuing an alert is crucial in preventing further harm.
  • This incident highlights the importance of rigorous quality control and testing procedures in the pharmaceutical industry.
  • Transparency and clear communication with the public are essential during such health crises.
  • The availability of a toll-free number, though limited in hours, provides a channel for public reporting and information dissemination.

Impact Analysis:

This incident is likely to have several far-reaching impacts:

  • Increased Scrutiny of Pharmaceutical Manufacturing: There will be increased scrutiny of pharmaceutical manufacturers, particularly those producing medications for children, to ensure adherence to quality control standards and prevent future contamination incidents.
  • Review of Supply Chain Processes: A comprehensive review of the pharmaceutical supply chain is expected, focusing on identifying vulnerabilities and implementing measures to prevent the introduction of adulterated or substandard products.
  • Strengthening of Regulatory Oversight: The CDSCO and state-level drug control administrations may face pressure to strengthen their regulatory oversight and enforcement capabilities to effectively monitor and regulate the pharmaceutical industry.
  • Erosion of Public Trust: This incident could erode public trust in the pharmaceutical industry and government regulatory bodies, necessitating efforts to restore confidence through transparent investigations and corrective actions.
  • Potential Legal Ramifications: Tridus Remedies may face legal action and penalties if found liable for negligence or violations of drug safety regulations. The victims of the contaminated syrup may also pursue legal recourse.

    Read More

Related News: